14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

ICPT Predictions History

5 years ago
Karim predicted that ICPT for 2019-04-30 is going $113.14 (28.02%)

Rank:

5 years ago
NameNotImportant predicted that ICPT for 2019-04-29 is going $91.36 (1.86%)

5 years ago
JS predicted that ICPT for 2019-04-23 is going $86.51 (-4.44%)

5 years ago
NameNotImportant predicted that ICPT for 2019-04-23 is going $85.46 (-5.60%)

5 years ago
PumpTheseNumbers predicted that ICPT for 2019-04-23 is going $89.20 (-1.47%)

5 years ago
Karim predicted that ICPT for 2019-04-23 is going $116.32 (28.49%)

Rank:

5 years ago
JS predicted that ICPT for 2019-02-08 is going $114.92 (-3.35%)

5 years ago
Tim predicted that ICPT for 2019-02-08 is going $116.23 (-2.25%)

Rank:

7 years ago
JS predicted that ICPT for 2017-04-13 is going $105.01 (-2.16%)

7 years ago
Dr§hocker predicted that ICPT for 2017-04-13 is going $105.22 (-1.97%)

Rank:
Click to get the best stock tips daily for free!

About Intercept Pharmaceuticals

Intercept Pharmaceuticals Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nona... ICPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT